The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDFX.L Regulatory News (DFX)

  • There is currently no data for DFX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

1 Oct 2018 18:29

RNS Number : 6075C
Defenx plc
01 October 2018
 

1 October 2018

Defenx PLC("Defenx" or the "Company" or the "Group")

 

Unaudited Interim Results for the six months ended 30 June 2018

 

Set out below are the interims results for Defenx for the six months ended 30 June 2018.

 

Chairman's Statement

 

We are releasing the unaudited interim results for the six months ended 30 June 2018 alongside our annual report and accounts for the year to 31 December 2017 ("2017 Accounts").

 

As documented in detail in the 2017 Accounts, the Group has been focused on addressing performance and back-end integration issues in respect of its products in the year to date. The Group has also been enhancing its product portfolio as part of its Defenx 2020 strategy, and we currently anticipate launching new products in Q1 2019.

 

This has resulted in there being minimal customer invoicing during H1 2018 and revenue for the period relates predominantly to the release of previously deferred income and this is expected to continue in H2 2018. Given this backdrop, we have sought to minimise operating overheads during the period.

 

The reduction in trading activity has also been accompanied by a cessation of marketing contributions to distributors. A as a result, at an operational level, the loss for the half year is very similar to the corresponding period in 2017. However, 2018 bears additional interest costs in relation to the bonds issued in August 2017, whilst there was a substantially larger tax credit in 2017.

 

The major changes in the statement of financial position are primarily attributable to the comprehensive impairment provisions made at 31 December 2017 as detailed in the 2017 Accounts. Following the period end, settlement agreements were reached with four of the Group's B2B2C customers. The agreements waive the parties' claims against each other, set out payment schedules for the collection over a period of up to 48 months of approximately 20.4% of the €4.41 million in dispute at 31 December 2017 and committed the Group to exchange specified unsold inventory held by the customers for new products, such new products being subject to normal commercial warranties. Accordingly, the Directors considered that no further provision were warranted as at 30 June 2018.

 

Board

 

In the year to date, there have been a number of changes to the Board and senior management. As previously announced, this has resulted in me becoming interim Executive Chairman in May and Raffaele Boccardo assuming the role of interim Executive Deputy Chairman in July. At the same time, Clive Eplett was appointed as interim Chief Financial Officer. Board departures in the period have resulted in one-off costs of, in aggregate, €250,000.

 

Following the period end, we were delighted to welcome Nic Hellyer and Giorgio Beretta, two high calibre individuals, as independent Non-executive Directors and chair of the Remuneration and Audit Committees respectively, filling the vacancies left by Leonard Seelig.

 

The Board are seeking to identify and recruit the right team to deliver our strategy and drive value for all stakeholders and we look forward to keeping shareholders updated on our progress particularly with regard to the appointment of a CEO and a permanent CFO.

 

Funding

 

During the period, the Company raised £1.2 million (gross) (approximately €1.38 million) for general working capital purposes by way of a subscription and open offer, pursuant to which the Company issued 14,962,899 new ordinary shares at a price of 8 pence per share. Following BV Tech SpA's ("BV Tech") participation in the fundraise, BV Tech's interest in the Company increased to 54.7% of the Company's issued share capital.

 

The Group has today secured further funding of €0.95 million via an unsecured loan from BV Tech. The loan, which accrues interest at a rate of 6% per annum, will be used for general corporate purposes. The Board anticipates that the loan will shortly be replaced by a convertible loan from BV Tech of the same quantum and on the same material terms. Conversion of the convertible loan into ordinary shares is subject to shareholders providing the Directors with authority at the upcoming annual general meeting on 31 October 2018 to allot such shares on a non pre-emptive basis.

 

Outlook

 

As a result of the issues raised above and detailed in the 2017 Accounts, the results for 2018 are expected to show minimal revenues and an operating loss. However, as a result of the initiatives put in place as part of Defenx 2020, the Board believes that the business will become cashflow positive during 2019.

 

Following the publication of the 2017 Accounts and these interims, the Company is pleased to announce that it is expected that trading in the Company's ordinary shares on AIM will be restored at 7:30 a.m. on 2 October 2018.

 

Anthony Reeves

Executive Chairman

1 October 2018

 

Enquiries

Defenx PLCAnthony Reeves -Executive ChairmanClive Eplett - Interim Chief Financial Officer

020 3769 0687

Strand Hanson Limited (Nominated and Financial Advisor)Stuart Faulkner / Richard Tulloch / James Bellman

020 7409 3494

WH Ireland (Joint-Broker)Adrian Hadden / Jessica Cave

020 7220 1666

IFC Advisory (Financial PR and IR)Graham Herring / Tim Metcalfe / Heather Armstrong

020 3053 8671

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

About Defenx

Founded in 2009, Defenx is a cyber-security software group that offers a range of Security, Backup and Protection solutions for smartphones, PCs and networks.

 

Website

www.defenx.com/company/investors

 

Unaudited Interim Condensed Consolidated Statement of Comprehensive Income

 

6 months ended

6 months ended

Year ended

30 June 2018

Unaudited

30 June 2017

Unaudited

31 December 2017

Audited

Note

€000

€000

€000

Revenue

5

701

3,134

2,928

Cost of sales

6

(670)

(965)

(2,553)

----------------------

----------------------

----------------------

Gross profit

31

2,169

375

Other operating income

6

101

-

772

Sales & marketing expenses

6

(182)

(2,411)

(1,975)

Research, development & operations' expenses

6

(514)

(451)

(712)

Administrative expenses

6

(947)

(619)

(906)

Impairment of trade receivables

-

-

(3,020)

Impairment of intangible fixed assets

-

-

(6,286)

Operating expenses before transaction costs

(1,643)

(3,481)

(12,899)

Operating loss before transaction costs

(1,511)

(1,312)

(11,752)

Transaction costs

6

-

(101)

(101)

---------------------

---------------------

---------------------

Loss from operations

(1,511)

(1,413)

(11,853)

Finance income

-

-

1

Finance expense

(138)

(68)

(184)

----------------------

----------------------

----------------------

Loss before tax

(1,649)

(1,481)

(12,036)

Income tax credit

5

325

235

----------------------

----------------------

----------------------

Loss for the period

(1,644)

(1,156)

(11,801)

----------------------

----------------------

----------------------

Attributable to:

Equity holders of the parent

(1,598)

(1,146)

(11,641)

Non-controlling interests

(46)

(10)

(160)

----------------------

----------------------

----------------------

Total comprehensive loss for the period

(1,644)

(1,156)

(11,801)

===========

===========

===========

Loss per share

Basic

7

(€0.069)

(€0.097)

(€1.030)

Diluted

7

(€0.067)

(€0.095)

(€0.976)

 

Unaudited Interim Condensed Consolidated Statement of Financial Position

 

30 June 2018

Unaudited

30 June 2017

Unaudited

31 December 2017

Audited

Note

€000

€000

€000

Non-current assets

Property, plant and equipment

136

124

135

Intangible assets

8

4,320

11,593

4,904

Government grant

1,522

-

1,596

----------------------

----------------------

----------------------

5,978

11,717

6,635

----------------------

----------------------

----------------------

Current assets

Trade and other receivables

9

1,218

4,387

1,243

Government grant

168

-

179

Cash and short-term deposits

791

218

951

----------------------

----------------------

----------------------

2,177

4,605

2,373

----------------------

----------------------

----------------------

Total assets

8,155

16,322

9,008

===========

===========

===========

Current liabilities

Trade and other payables

(1,146)

(588)

(851)

Deferred revenue

(392)

(385)

(621)

Loans and borrowings

10

(379)

(1,417)

(663)

Deferred consideration

-

(381)

-

Income taxes payable

(389)

(398)

(385)

----------------------

----------------------

----------------------

(2,306)

(3,169)

(2,520)

----------------------

----------------------

----------------------

Non-current liabilities

Deferred revenue

(744)

(235)

(887)

Loans and borrowings

10

(1,423)

(242)

(1,533)

Deferred tax liabilities

(37)

(47)

(42)

----------------------

----------------------

----------------------

(2,204)

(524)

(2,462)

----------------------

----------------------

----------------------

Total liabilities

(4,510)

(3,693)

(4,982)

===========

===========

===========

Net assets

3,645

12,629

4,026

===========

===========

===========

Capital and reserves

Called up share capital

11

601

264

287

Share premium

11

12,329

9,583

11,370

Merger reserve

1,641

1,641

1,641

Shares to be issued reserve

-

-

37

Convertible bond option reserve

164

-

164

Share based payment reserve

237

183

210

Retained earnings

(11,146)

947

(9,548)

----------------------

----------------------

----------------------

Attributable to equity holders of the parent

3,826

12,618

4,161

Non-controlling interests

(181)

11

(135)

----------------------

----------------------

----------------------

Total equity

3,645

12,629

4,026

===========

===========

===========

Unaudited Interim Condensed Consolidated Statement of Changes in Equity

 

 

Share capital

Share premium account

Merger reserve

Shares to be issued reserve

Convertible bondoption reserve

Share based payment reserve

Retained earnings

Total

Non-controlling interests

Total

€000

€000

€000

€000

€000

€000

€000

€000

€000

€000

As at 1 January 2018

287

11,370

1,641

37

164

210

(9,548)

4,161

(135)

4,026

Share based payments

-

-

-

-

-

27

-

27

-

27

Loss for the period

-

-

-

-

-

-

(1,598)

(1,598)

(46)

(1,644)

Shares issued

314

959

-

(37)

-

-

-

1,236

-

1,236

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

As at 30 June 2018

601

12,329

1,614

-

164

237

(11,146)

3,826

(181)

3,645

(unaudited)

==========

==========

==========

==========

==========

==========

==========

==========

==========

==========

As at 1 January 2017

197

5,542

1,641

-

-

156

2,093

9,629

21

9,629

Share based payments

-

-

-

-

-

27

-

27

-

27

Loss for the period

-

-

-

-

-

-

(1,146)

(1,146)

(10)

(1,146)

Shares issued

67

4,041

-

-

-

-

-

4,108

-

4,108

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

-------------------

As at 30 June 2017

264

9,583

1,641

-

-

183

947

12,618

11

12,629

(unaudited)

==========

==========

==========

==========

==========

==========

==========

==========

==========

==========

As at 1 January 2017

197

5,542

1,641

-

-

156

2,093

9,629

21

9,650

Loss for the year

-

-

-

-

-

-

(11,641)

(11,641)

(160)

(11,801)

Shares issued

90

5,828

-

-

-

-

-

5,918

4

5,922

Shares to be issued

-

-

-

37

-

-

-

37

-

37

Convertible bond issue

-

-

-

-

164

-

-

164

-

164

Share based payments

-

-

-

-

-

54

-

54

-

54

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

--------------------

-------------------

As at 31 December

287

11,370

1,641

37

164

210

(9,548)

4,161

(135)

4,026

(audited)

==========

==========

==========

==========

==========

==========

==========

==========

==========

==========

 

Unaudited Interim Condensed Consolidated Cash Flow Statement

 

6 months ended 30 June 2018

Unaudited

6 months ended 30 June 2017

Unaudited

Year ended

31 December 2017

Audited

€000

€000

€000

Cash flows from operating activities

Loss for the period after taxation

(1,644)

(1,156)

(11,801)

Income tax (credit)/expense

(5)

(325)

(235)

----------------------

----------------------

----------------------

Loss before tax

(1,649)

(1,481)

(12,036)

 

Net interest expense

138

68

184

Depreciation of property, plant and equipment

-

22

47

Amortisation of intangible assets

590

865

1,292

Impairment of intangible assets

-

-

6,286

Impairment of trade receivables

-

-

3,020

Share based payments expense

27

27

54

----------------------

----------------------

----------------------

Operating cash flows before movements in working capital

(894)

(499)

(1,153)

----------------------

----------------------

----------------------

Decrease in trade receivables

284

1,146

1,011

Increase/(decrease) in trade and other payables

75

(801)

(1,738)

(Decrease)/increase in deferred revenue

(457)

28

(86)

----------------------

----------------------

----------------------

(98)

373

(813)

----------------------

----------------------

----------------------

Interest paid

(84)

(68)

(146)

Tax paid

(6)

(62)

(215)

----------------------

----------------------

----------------------

Net cash flow from operating activities

(1,082)

(256)

(2,327)

----------------------

----------------------

----------------------

Investing activities

Purchase of property, plant and equipment

(1)

(4)

(51)

Development costs - internally developed

(6)

(1,805)

(1,828)

----------------------

----------------------

----------------------

Net cash used in investing activities

(7)

(1,809)

(1,879)

----------------------

----------------------

----------------------

Financing activities

Net proceeds from issue of share capital

1,377

1,397

3,440

Proceeds from borrowings

-

5

1,750

Repayment of borrowings

(426)

(254)

(1,070)

----------------------

----------------------

----------------------

Net cash from financing activities

951

1,148

4,120

----------------------

----------------------

----------------------

Net decrease in cash and cash equivalents

(138)

(917)

(86)

Cash and cash equivalents at beginning of period

929

1,015

1,015

----------------------

----------------------

----------------------

Cash and net cash equivalents at end of period

791

98

929

===========

===========

===========

Notes to the Unaudited Interim Condensed Consolidated Financial Statements

1. General information

Defenx PLC is a public limited company incorporated in England and Wales, registration number 08993398, which is quoted on AIM. Its principal activity is the design and sale of software solutions for the mobile, PC and network that provide privacy and security for an online world. Management and control is exercised from the UK and its main countries of operation are Italy and Switzerland.

2. Basis of preparation

The unaudited interim condensed consolidated financial statements for the six months ended 30 June 2018 have been prepared in accordance with IAS 34 Interim Financial Reporting and do not constitute statutory financial statements. They do not include all the information and disclosures required for a complete set of IFRS financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 December 2017. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last financial statements.

These unaudited interim financial statements were authorised for issue by Defenx's Board on 1 October 2018.

3. Accounting policies

There have been no changes to the accounting policies and methods of computation in these financial statements compared with those of the previous full year.

Note: IFRS 15 Revenue from contracts with customers, became effective for annual periods beginning on or after 1 January 2018. Having assessed the commercial arrangements with customers in the context of IFRS15, the Board concluded that the existing accounting policy and methodology continues to be equally appropriate under the new accounting standard. Accordingly, no change in accounting treatment arises or has been applied as a consequence of IFRS 15 and no adjustment made to either sales or deferred revenue.

4. Seasonality

Historically, the Group's revenue generated by and marketing contributions paid to channel partners was subject to seasonal trends.

A larger proportion of the annual marketing contributions arose in the first half of the year to support channel partners, who in turn generated higher sales in the second half of the year driven by the back-to-school market, annual hardware release cycles and Christmas trading. This typically lowered revenues and profits for the first half of the year. The Group sought to mitigate the seasonal impact by incentivising sales in the first half of the year.

Changes in the trading relationships with those distributors resulted in marketing contributions not being made in 2018, negating most of this seasonal characteristic.

5. Revenue

Revenue for the full year was impacted by the return of €1.03 million in invoiced sales from the first half of 2017, as a consequence of delays in the delivery of product updates to address performance issues in the Group's security products.

 

6. Loss from operations

6 months ended30 June 2018Unaudited

6 months ended30 June 2017Unaudited

Year ended31 December 2017Audited

 

The operating loss is stated after charging:

€000

€000

€000

 

 

Cost of sales

 

Amortisation of intangible assets

590

865

1,292

 

===========

===========

===========

 

 

Other operating income

 

Research & development tax credit income

(101)

-

(772)

 

 

Sales, marketing and administrative expenses

 

Marketing contributions

5

2,232

1,550

 

Impairment of trade receivables

-

-

3,020

 

Depreciation of property, plant and equipment

-

22

48

 

Impairment of intangible assets

-

-

6,286

 

Staff costs

679

599

1,278

 

Auditors' remuneration - audit services

22

17

49

 

Auditors' remuneration - non-audit Services

2

2

9

 

Share based payment expense

27

27

53

 

Bad debt expense

-

104

-

 

Lease payments - land and buildings

49

52

116

 

Net foreign exchange losses/(gains)

7

16

(61)

 

AIM-related expenses

100

113

234

 

===========

===========

===========

 

Transaction costs

 

Legal & professional fees in respect of theBV-Tech SpA strategic partnership

-

101

101

 

===========

===========

===========

 

 

7. Loss per share (EPS)

Basic EPS amounts are calculated by dividing the profit for the period attributable to ordinary equity holders of Defenx by the weighted average number of ordinary shares outstanding during the period.

Diluted EPS amounts are calculated by dividing the profit attributable to ordinary equity holders of Defenx by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on conversion of all the dilutive deferred shares, the exercise of options and crystallisation of the contingent share consideration.

The following reflects the income and share data used in the basic and diluted EPS computations:

6 months ended30 June 2018Unaudited

6 months ended30 June 2017Unaudited

Year ended31 December 2017Audited

€000

€000

€000

(Loss)/profit attributable to ordinary equity holders of Defenx PLC for basic and adjusted EPS

(1,580)

 

(1,146)

 

(11,641)

===========

===========

===========

Weighted average number of Ordinary Shares for basic EPS (thousand)

22,905

11,777

11,237

Effect of:

- dilution from convertible bond

625

-

625

- dilution from share options and warrants

-

72

-

- contingent shares on acquisition of Memopal Srl

-

238

-

----------------------

----------------------

----------------------

Weighted average number of Ordinary Shares for

23,530

12,087

11,862

diluted EPS (thousands)

===========

===========

===========

 

8. Intangible Assets

Goodwill

Development costs

Customer relationships

Total

€000

€000

€000

€000

Cost

At 1 January 2018

1,139

12,635

354

14,128

Additions - internally developed

-

-

-

-

Additions - purchased

-

6

-

6

----------------------

----------------------

----------------------

----------------------

At 30 June 2018

1,139

12,641

354

14,134

===========

===========

===========

===========

Accumulated amortisation

At 1 January 2018

1,139

7,731

354

9,224

Amortisation charge

-

590

-

590

---------------------

----------------------

----------------------

----------------------

At 30 June 2018 (unaudited)

1,139

8,321

354

9,814

===========

===========

===========

===========

Net book value

At 30 June 2018 (unaudited)

-

4,320

-

4,320

===========

===========

===========

===========

At 30 June 2017 (unaudited)

1,139

10,208

246

11,593

===========

===========

===========

===========

At 31 December 2017 (audited)

-

4,904

-

4,904

===========

===========

===========

===========

The intangible assets booked represent qualifying expenditure on the development of software for resale less accumulated amortisation and impairment costs. The carrying value of these intangible assets is tested for impairment on a half yearly basis, or when there are indications that the value of the assets might be impaired.

The Directors have assessed development projects' individual net present value against forecasts of future sales of the related products, unit sales prices and costs over a five-year period. No sales beyond five years have been included in the calculations. The impairment tests are sensitive to changes in these forecasts and changes could result in impairment; however, the varying bases indicate a net present value in excess of the carrying value of the intangible assets at the balance sheet date.

9. Trade and other receivables

6 months ended30 June 2018Unaudited

6 months ended30 June 2017Unaudited

Year ended31 December 2017Audited

€000

€000

€000

Gross trade receivables

4,682

4,491

4,833

Offset deferred revenue

(454)

-

(619)

Provision for impairment

(3,217)

(301)

(3,217)

----------------------

----------------------

----------------------

Net trade receivables

1,011

4,190

997

Other receivables

207

197

246

----------------------

----------------------

----------------------

Total receivables

1,218

4,387

1,243

===========

===========

===========

Provisions for impairment

Opening balance

(3,217)

(197)

(196)

Utilised during the period

-

-

-

Net increase during the period

-

(104)

(3,021)

----------------------

----------------------

----------------------

Closing balance

(3,217)

(301)

(3,217)

===========

===========

===========

10. Loans and borrowing

The book and fair value of interest bearing loans and borrowings was:

Ultimatematurity

6 months ended30 June 2018Unaudited

6 months ended30 June 2017Unaudited

Year ended31 December 2017Audited

€000

€000

€000

Current

Overdrafts

On demand

-

25

22

On demand

-

95

-

Invoice discounting facility

Up to 120 days

-

94

77

Supply chain facility

Up to 90 days

-

504

-

Bank loans - unsecured

30/06/2019

203

197

200

Bank loans - unsecured

22/11/2021

123

-

122

Vendor loans from business combinations

31/07/2018

53

502

242

----------------------

----------------------

----------------------

379

1,417

663

----------------------

----------------------

----------------------

 

 

Non-current

Bank loans - unsecured

30/06/2019

-

203

103

Bank loans - unsecured

22/11/2021

306

-

368

Vendor loans from business combinations

31/07/2018

-

39

Convertible bonds

31/08/2020

1,117

-

1,062

----------------------

----------------------

----------------------

1,423

242

1,533

----------------------

----------------------

----------------------

Total loans and borrowing

1,802

1,659

2,196

===========

===========

===========

Overdrafts and other short term facilities, excluding the supply chain facility, attract variable interest at between 3% and 6% per annum. The supply chain facility, denominated in Sterling, attracts a fixed rate of interest of 1.65% per month. The bank and vendor loans, both denominated in Euros, attract interest at 3% over 3-month EURIBOR and at 8% fixed per annum respectively.

The average effective interest rate for the period ended 30 June 2018 was 7.5% (30 June 2017: 10.2%).

At 30 June 2018, the Group had available €270,000 (30 June 2017: €123,331) of undrawn committed borrowing facilities. Of this amount, €250,000 relates to supply chain facility, use of which is dependent on applicable sales invoicing.

11. Share capital

Number of shares

Share capital

Share premium

€000

€000

As at 1 January 2018

12,952

287

11,370

Issue of new ordinary shares - BV-Tech SpA

11,777

244

840

Issue of new ordinary shares - Open offer

3,186

66

227

Issue of new ordinary shares - MBooster

243

4

51

Equity issue costs

-

-

(159)

------------------------

------------------------

------------------------

As at 30 June 2018 (unaudited)

28,158

601

12,329

As at 1 January 2017

8,618

196

5,542

Issue of new ordinary shares - BV-Tech SpA

3,144

68

4,041

Issue of new ordinary shares - MBooster

22

-

37

Equity issue costs

-

-

(59)

Exercise of Warrants

15

-

22

------------------------

------------------------

------------------------

As at 30 June 2017 (unaudited)

11,799

264

9,583

============

===========

===========

The ordinary shares of £0.018 carry the right to one vote per share at general meetings of the Company and the rights to share in any distribution of profits or returns of capital and to share in any residual assets available for distribution in the event of a winding up. The shares are denominated in Sterling.

12. Events after the reporting date

During October 2018, settlement agreements were reached with four B2B2C customers. These agreements waived the parties' claims against each other, set out payment schedules for the collection over a period of up to 48 months of approximately 20.4% of the €4.41 million in dispute at 31 December 2017 and committed the Group to exchange specified unsold inventory held by the customers for new products, such new products being subject to normal commercial warranties.

On 1 October 2018, the Company entered into a €0.95 million unsecured loan agreement with BV Tech. The loan will incur an interest rate of 6% per annum, payable quarterly in arrears, and is repayable in full on 1 January 2020, or earlier at the Company's election. Under the terms of the Loan, €150,000 can be drawn down immediately, with the remainder being available to be draw down in full, or in part, after 45 days. It is intended that the proceeds of the loan will be used for general corporate purposes. As BV Tech is a substantial shareholder of the Company as defined in the AIM Rules for Companies, the loan is classified as a related party transaction pursuant to AIM Rule 13. The Board expects that the loan will, shortly following publication of the Company's annual report and accounts for the year ended 31 December 2017 and the interims for the six months ended 30 June 2018, be replaced by a convertible loan from BV Tech of the same quantum and on the same material terms.

13. Availability of the interims

The Interim Report will shortly be available on the Company's website at www.investors.defenx.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR QFLFBVBFEFBK
Date   Source Headline
6th Jan 20205:09 pmRNSDelisting from AIM & Result of Exit Opportunity
2nd Jan 20207:00 amRNSNotification of Interest re Exit Opportunity
31st Dec 20191:15 pmRNSDefenx
27th Dec 201910:00 amRNSNotification of Interest re Exit Opportunity
24th Dec 201910:42 amRNSNotification of Interest re Exit Opportunity
20th Dec 201911:45 amRNSResult of General Meeting & Cancellation
20th Dec 20197:00 amRNSNotification of Interest re Exit Opportunity
18th Dec 20197:00 amRNSNotification of Interests re Exit Opportunity
13th Dec 20194:32 pmRNSOffer by BV Tech to bondholders
13th Dec 20194:21 pmRNSAgreement and Offer to Purchase Defenx PLC Bonds
13th Dec 20197:00 amRNSNotification of Interest re Exit Opportunity
10th Dec 20197:00 amRNSNotification of Interest re Exit Opportunity
6th Dec 20197:00 amRNSNotification of Interest re Exit Opportunity
4th Dec 20192:58 pmRNSExit Opportunity to Minority Shareholders
4th Dec 20192:45 pmRNSCancellation, exit opportunity & notice of GM
27th Nov 20197:00 amRNSUpdate re proposed cancellation
11th Nov 20194:35 pmRNSPrice Monitoring Extension
4th Nov 20197:00 amRNSProposed cancellation of admission to AIM
30th Sep 20193:48 pmRNSInterim Results
2nd Sep 201912:25 pmRNSResult of AGM
29th Jul 20195:29 pmRNSPosting of Annual Report and Notice of AGM
29th Jul 20197:30 amRNSRestoration - Defenx Plc
29th Jul 20197:00 amRNSResults for the Year Ended 31 December 2018
1st Jul 20197:30 amRNSSuspension of trading on AIM
1st Jul 20197:30 amRNSSuspension - Defenx Plc
9th Apr 20197:00 amRNSBV Tech Distribution Agreement
18th Mar 20197:00 amRNSLoan draw down & conversion and corporate update
4th Jan 20192:30 pmRNSFurther Drawn Down of Loan
31st Oct 20183:50 pmRNSResult of AGM and Issue of Equity
31st Oct 20187:00 amRNSAGM Statement
18th Oct 20187:00 amRNSConversion Notice Received
16th Oct 201812:45 pmRNSFirst draw down under the Convertible Loan
3rd Oct 20187:00 amRNSNotice of AGM
2nd Oct 20187:30 amRNSRestoration - Defenx plc
2nd Oct 20187:00 amRNSConvertible Loan from BV Tech
1st Oct 20186:29 pmRNSInterim Results
1st Oct 20186:29 pmRNSFull Year Results
1st Oct 20186:19 pmRNSLoan from BV Tech
28th Sep 20187:00 amRNSUpdate on Accounts and Financial Position
2nd Aug 20187:00 amRNSBoard Appointments
16th Jul 20187:00 amRNSUpdate on Trading and Financial Position
11th Jul 201810:30 amRNSBoard and Management Changes
2nd Jul 20187:30 amRNSSuspension - Defenx Plc
29th Jun 20183:50 pmRNSSuspension of trading on AIM
25th May 20187:00 amRNSResignation of Director
24th Apr 20185:56 pmRNSResignation of Director
23rd Apr 20186:13 pmRNSResult of Open Offer and General Meeting
20th Apr 201811:05 amRNSSecond Price Monitoring Extn
20th Apr 201811:00 amRNSPrice Monitoring Extension
6th Apr 20187:00 amRNSProposed Subscription and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.